NASDAQ: ARVNArvinas Inc Stock Ownership - Who owns Arvinas?
Insider buying vs selling
Have Arvinas Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Andrew Saik | Chief Financial Officer | 2025-06-24 | 5,700 | $7.61 | $43.38kSell |
| Angela M. Cacace | Chief Scientific Officer | 2025-06-17 | 2,583 | $7.49 | $19.35kSell |
| Noah Berkowitz | Chief Medical Officer | 2025-03-18 | 8,658 | $8.59 | $74.37kSell |
| John G. Houston | President and CEO | 2025-02-24 | 26,184 | $16.75 | $438.58kSell |
| John G. Houston | President and CEO | 2025-02-24 | 5,154 | $16.55 | $85.30kSell |
| David K. Loomis | Chief Accounting Officer | 2025-02-24 | 1,214 | $16.75 | $20.33kSell |
| Ian Taylor | President RD | 2025-02-24 | 7,356 | $16.75 | $123.21kSell |
| Ian Taylor | President RD | 2025-02-24 | 1,664 | $16.55 | $27.54kSell |
| Angela M. Cacace | Chief Scientific Officer | 2025-02-24 | 3,061 | $16.75 | $51.27kSell |
| Angela M. Cacace | Chief Scientific Officer | 2025-02-24 | 1,146 | $16.55 | $18.97kSell |
ARVN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ARVN insiders and whales buy or sell their stock.
ARVN Shareholders
What type of owners hold Arvinas Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 11.46% | 8,362,200 | $65.14M | Institution |
| Timothy M. 1. Shannon | 8.53% | 6,223,325 | $48.48M | Insider |
| Blackrock Inc | 8.45% | 6,169,602 | $48.06M | Institution |
| Citadel Advisors LLC | 5.31% | 3,875,846 | $30.19M | Institution |
| Price T Rowe Associates Inc | 5.24% | 3,825,064 | $29.80M | Institution |
| Canaan IX LP | 4.92% | 3,589,554 | $27.96M | Insider |
| Pfizer Inc | 4.74% | 3,457,815 | $26.94M | Institution |
| Rtw Investments LP | 4.57% | 3,334,308 | $25.97M | Institution |
| Ra Capital Management LP | 4.30% | 3,138,412 | $24.45M | Insider |
| Craig Martin Crews | 2.89% | 2,106,692 | $16.41M | Insider |
ARVN vs Biotech Stocks
Arvinas Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.